# RNA on Display: Cell Surface RNA as a Novel Layer of Cellular Regulation

**Authors:** Serina Chahal, Pious Jose, Adam Greasley, Kevin Vytlingam, Raj Kumar Thapa, Hayley Pyne, Amal Abu Omar, Xiufen Zheng

PMC · DOI: 10.34133/research.1147 · Research · 2026-02-27

## TL;DR

This paper reviews recent discoveries about RNA found on the surface of cells and its potential role in cellular communication and disease.

## Contribution

The paper introduces cell surface glycoRNAs as a novel regulatory layer and summarizes recent advances in their detection and function.

## Key findings

- Cell surface RNAs are modified with sialylated glycans and found on immune and cancer cells.
- Recent techniques have enabled detection and isolation of cell surface glycoRNAs.
- Cell surface RNA may offer new insights into immunomodulation and disease mechanisms.

## Abstract

RNA has been established as an essential molecule in virtually all cellular processes. Besides its role in cellular modulation via extracellular vesicular release, it has long been thought to only exert its function intracellularly. Recent discoveries have shown evidence of extracellular RNA tethered to the cell surface of different cell types. These cell surface RNAs are predominantly modified with sialylated glycans, denominating them cell surface glycoRNAs. While the expression of cell surface glycoRNAs has been found on a wide array of immune cell and cancer cell types, research on its functional roles has only recently been explored due to challenges in detection, isolation, and sequencing of this new subclass of RNA. In this review, the history, biogenesis, detection and isolation techniques, and functional roles of cell surface RNA to date will be discussed, in addition to commenting on its translational capacity for studying immunomodulation and disease. Acknowledging the presence of cell surface RNAs and propelling our understanding on their function will provide a new avenue to study cellular modulation and cell–cell communication.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** TAT (tyrosine aminotransferase) [NCBI Gene 6898], SIDT2 (SID1 transmembrane family member 2) [NCBI Gene 51092] {aka CGI-40}, COL12A1 (collagen type XII alpha 1 chain) [NCBI Gene 1303] {aka BA209D8.1, BTHLM2, COL12A1L, DJ234P15.1, EDSMYP, UCMD2}, STT3A (STT3 oligosaccharyltransferase complex catalytic subunit A) [NCBI Gene 3703] {aka CDG1WAD, CDG1WAR, ITM1, STT3-A, TMC}, COL5A1 (collagen type V alpha 1 chain) [NCBI Gene 1289] {aka EDSC, EDSCL1, FMDMF}, RBP4 (retinol binding protein 4) [NCBI Gene 5950] {aka MCOPCB10, RDCCAS}, MCF2L (MCF.2 cell line derived transforming sequence like) [NCBI Gene 23263] {aka ARHGEF14, DBS, OST}, NKG7 (natural killer cell granule protein 7) [NCBI Gene 4818] {aka GIG1, GMP-17, p15-TIA-1}, SELPLG (selectin P ligand) [NCBI Gene 6404] {aka CD162, CLA, PSGL-1, PSGL1}, KIR2DL5A (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A) [NCBI Gene 57292] {aka CD158F, KIR2DL5, KIR2DL5.1, KIR2DL5.3}, NEAT1 (nuclear paraspeckle assembly transcript 1) [NCBI Gene 283131] {aka LINC00084, NCRNA00084, TP53LC15, TncRNA, VINC}, SELP (selectin P) [NCBI Gene 6403] {aka CD62, CD62P, GMP140, GRMP, LECAM3, PADGEM}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, CD14 (CD14 molecule) [NCBI Gene 929], HOXB8 (homeobox B8) [NCBI Gene 3218] {aka HOX2, HOX2D, Hox-2.4}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, SELE (selectin E) [NCBI Gene 6401] {aka CD62E, ELAM, ELAM1, ESEL, LECAM2, selectin-e}, CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, MS4A1 (membrane spanning 4-domains A1) [NCBI Gene 931] {aka B1, Bp35, CD20, CVID5, FMC7, LEU-16}, Rnase1 (ribonuclease, RNase A family, 1 (pancreatic)) [NCBI Gene 19752] {aka Rib-1, Rib1}, TLR7 (toll like receptor 7) [NCBI Gene 51284] {aka IMD74, SLEB17, TLR7-like}, RXRA (retinoid X receptor alpha) [NCBI Gene 6256] {aka NR2B1, RXR-alpha, RXRalpha}, CALR (calreticulin) [NCBI Gene 811] {aka CALR1, CRT, HEL-S-99n, RO, SSA, cC1qR}, SPON2 (spondin 2) [NCBI Gene 10417] {aka DIL-1, DIL1, M-SPONDIN, MINDIN}, SIDT1 (SID1 transmembrane family member 1) [NCBI Gene 54847] {aka SID-1, SID1}, CNN1 (calponin 1) [NCBI Gene 1264] {aka HEL-S-14, SMCC, Sm-Calp}, MGAT1 (alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase) [NCBI Gene 4245] {aka GLCNAC-TI, GLCT1, GLYT1, GNT-1, GNT-I, GnTI}, TALAM1 (TALAM1 transcript, MALAT1 antisense RNA) [NCBI Gene 109136579], MOGS (mannosyl-oligosaccharide glucosidase) [NCBI Gene 7841] {aka CDG2B, CWH41, DER7, GCS1}, PVR (PVR cell adhesion molecule) [NCBI Gene 5817] {aka CD155, HVED, NECL5, Necl-5, PVS, TAGE4}, STT3B (STT3 oligosaccharyltransferase complex catalytic subunit B) [NCBI Gene 201595] {aka CDG1X, SIMP, STT3-B}, HOTAIRM1 (HOXA transcript antisense RNA, myeloid-specific 1) [NCBI Gene 100506311] {aka HOXA-AS1, HOXA1-AS1, NCRNA00179}, DTWD2 (DTW motif tRNA-uridine aminocarboxypropyltransferase 2) [NCBI Gene 285605], CD3E (CD3 epsilon subunit of T-cell receptor complex) [NCBI Gene 916] {aka CD3epsilon, IMD18, T3E, TCRE}, MALAT1 (metastasis associated lung adenocarcinoma transcript 1) [NCBI Gene 378938] {aka HCN, LINC00047, NCRNA00047, NEAT2, PRO2853, miPEP-52}, TLR3 (toll like receptor 3) [NCBI Gene 7098] {aka CD283, IIAE2, IMD83}, MUC4 (mucin 4, cell surface associated) [NCBI Gene 4585] {aka ASGP, HSA276359, MUC-4}, mucin [NCBI Gene 100508689], RBFOX1 (RNA binding fox-1 homolog 1) [NCBI Gene 54715] {aka 2BP1, A2BP1, FOX-1, FOX1, HRNBP1}
- **Diseases:** viral (MESH:D014777), colon cancer (MESH:D015179), amyotrophic lateral sclerosis (MESH:D000690), metastasis (MESH:D009362), immune dysfunction diseases (MESH:D007154), infection (MESH:D007239), breast cancer (MESH:D001943), bacterial infection (MESH:D001424), pancreatic cancer (MESH:D010190), cervical carcinoma (MESH:D002583), melanoma (MESH:D008545), Glioma tumor (MESH:D005910), osteosarcoma (MESH:D012516), inflammation (MESH:D007249), spinal muscular atrophy (MESH:D009134), chronic myeloid leukemia (MESH:D015464), cancers (MESH:D009369), lung cancer (MESH:D008175), tumorigenesis (MESH:D063646), autoimmune disease (MESH:D001327), gastric cancer (MESH:D013274), lung adenocarcinoma (MESH:D000077192), microbial diseases (MESH:D015163), non- (MESH:C580335), squamous carcinoma (MESH:D002294), NSCLC (MESH:D002289), SLE (MESH:D008180), acute (MESH:D000208), acute myeloid leukemia (MESH:D015470), neurological disorders (MESH:D009461)
- **Chemicals:** glycosaminoglycans (MESH:D006025), 5-bromo-2-uridine (-), HS (MESH:D006497), N-acetylglucosamine (MESH:D000117), carbohydrate (MESH:D002241), serine (MESH:D012694), amine (MESH:D000588), sialic acids (MESH:D012794), LPS (MESH:D008070), lipid (MESH:D008055), threonine (MESH:D013912), L-fucose (MESH:D005643), N-acetylmannosamine (MESH:C002022), sugar (MESH:D000073893), N-azidoacetyl-mannosamine (MESH:C405953), Ac4ManNAz (MESH:C000622612), C (MESH:D002244), N-acetylneuraminic acid (MESH:D019158), monosaccharide (MESH:D009005), glycosphingolipids (MESH:D006028), N (MESH:D009584), azide (MESH:D001386), glycan (MESH:D011134), MB (MESH:D008751), Asn (MESH:D001216), Biotin (MESH:D001710)
- **Species:** Cricetulus griseus (Chinese hamster, species) [taxon 10029], Homo sapiens (human, species) [taxon 9606], Influenza A virus (no rank) [taxon 11320], Halalkalibacterium halodurans (species) [taxon 86665], Cricetus cricetus (black-bellied hamster, species) [taxon 10034], Mus musculus (house mouse, species) [taxon 10090], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]
- **Cell lines:** THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006), MCF-10A — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_0598), SKBR-3 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0033), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), EL4 — Mus musculus (Mouse), Mouse precursor T cell lymphoblastic lymphoma/leukemia, Cancer cell line (CVCL_0255), A431 — Homo sapiens (Human), Skin squamous cell carcinoma, Cancer cell line (CVCL_0037), U87 — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0022), LN229 — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0393), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), hAELVi — Homo sapiens (Human), Transformed cell line (CVCL_C1M0), AML3 — Homo sapiens (Human), Adult acute myeloid leukemia, Cancer cell line (CVCL_1619), Mel-525 — Homo sapiens (Human), Argininosuccinic aciduria, Finite cell line (CVCL_4Z87), NCI-H441 — Homo sapiens (Human), Lung papillary adenocarcinoma, Cancer cell line (CVCL_1561), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493), U2-OS — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0042), K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12946384/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12946384/full.md

## References

63 references — full list in the complete paper: https://tomesphere.com/paper/PMC12946384/full.md

---
Source: https://tomesphere.com/paper/PMC12946384